Literature DB >> 4562098

Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.

C J Glueck, S Ford, D Scheel, P Steiner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562098     DOI: 10.1001/jama.222.6.676

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Abnormal low density lipoproteins in children with familial hypercholesterolemia--effect of polyanion exchange resins.

Authors:  R Mordasini; F Twelsiek; P Oster; B Schellenberg; H Raetzer; C C Heuck; G Schlierf
Journal:  Klin Wochenschr       Date:  1978-08-15

Review 2.  An overview of lipid-lowering drugs.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.

Authors:  A Gustafson; A Lanner
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  Editorial: Diet and drugs for hyperlipidaemia.

Authors:  P J Scott
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

6.  Effect of colestipol on sterol metabolism in the rat.

Authors:  M Takahashi; A N Sarwal; R F Raicht; B I Cohen
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

7.  Effects of colestipol hydrochloride and neomycin sulfate on cholesterol turnover in the rat.

Authors:  W A Phillips; G L Elfring
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

8.  The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

Review 9.  Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 10.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.